Severe COVID-19 Infection in Post Renal Transplant Recipients: A Single Centre Report
Singla Harshit, T. Samra, V. Mahajan, D. B. Kanwar
Asian Journal of Research in Infectious Diseases · pp. 22–24 · Published 29 Aug 2022
10.9734/ajrid/2022/v11i130302Abstract
Kidney transplant recipients are immunocompromised and have been under the spotlight during the COVD-19 pandemic. In our ICU 27.7% of patients received remdesivir as compared to the previous study in which no remdesivir therapy was administered. We did not report any deterioration in renal function secondary to its administration but improved outcome in patients administered the same. Survival rates of patients are thus higher in our subset (53.6%), which included patients with only severe disease.
References (7)
- 1 Remdesivir for the Treatment of Covid-19 — Final Report [DOI]
- 2 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [DOI]
- 3 Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial [DOI]
- 4 Safety of Remdesivir in Patients With Acute Kidney Injury or CKD [DOI]
- 5 Covid-19 Infection in India: A Comparative Analysis of the Second Wave with the First Wave [DOI]
- 6 Mortality Prediction of COVID-19 Patients at Intensive Care Unit Admission [DOI]
- 7 COVID-19 infection in renal transplant patients: Early report from india [DOI]
Cited by 0
No indexed citations yet.
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
27
Page views
0
PDF downloads
4
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.